BioSmart Co.Ltd Total Liabilities
BioSmart Co.Ltd total liabilities. Based on the latest financial reports, BioSmart Co.Ltd (038460) has total liabilities worth ₩109.14 Billion KRW (≈ $73.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are BioSmart Co.Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BioSmart Co.Ltd (2010–2024)
Total liabilities of BioSmart Co.Ltd from 2010 to 2024. This chart illustrates how BioSmart Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 038460 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
BioSmart Co.Ltd Competitors by Total Liabilities
The table below lists competitors of BioSmart Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jeil Steel Mfg Co. Ltd
KQ:023440
|
Korea | ₩60.19 Billion |
|
Level Biotechnology
TWO:3118
|
Taiwan | NT$237.03 Million |
|
Comms Group Ltd
AU:CCG
|
Australia | AU$31.35 Million |
|
MFS Investment Grade Municipal Trust
NYSE:CXH
|
USA | $44.83 Million |
|
Modi Rubber Limited
NSE:MODIRUBBER
|
India | Rs-6.77 Billion |
|
Foamit Oyj
HE:FOAMIT
|
Finland | €28.84 Million |
|
Matriks Bilgi Dagitim Hizmetleri AS
IS:MTRKS
|
Turkey | TL264.43 Million |
|
Tycoons Worldwide Group (Thailand) Public Company Limited
BK:TYCN
|
Thailand | ฿1.94 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down BioSmart Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 038460 current and non-current assets.
Liquidity & Leverage Metrics
BioSmart Co.Ltd Total Liabilities Ratios Explained
BioSmart Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioSmart Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioSmart Co.Ltd (2010–2024)
The table below shows the annual total liabilities of BioSmart Co.Ltd from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩133.36 Billion ≈ $90.38 Million |
-3.66% |
| 2023-12-31 | ₩138.43 Billion ≈ $93.81 Million |
-1.44% |
| 2022-12-31 | ₩140.46 Billion ≈ $95.19 Million |
+10.81% |
| 2021-12-31 | ₩126.75 Billion ≈ $85.90 Million |
+77.40% |
| 2020-12-31 | ₩71.45 Billion ≈ $48.42 Million |
-8.49% |
| 2019-12-31 | ₩78.08 Billion ≈ $52.91 Million |
+28.22% |
| 2018-12-31 | ₩60.89 Billion ≈ $41.27 Million |
+26.93% |
| 2017-12-31 | ₩47.97 Billion ≈ $32.51 Million |
-9.43% |
| 2016-12-31 | ₩52.97 Billion ≈ $35.90 Million |
+236.18% |
| 2015-12-31 | ₩15.76 Billion ≈ $10.68 Million |
-8.94% |
| 2014-12-31 | ₩17.30 Billion ≈ $11.73 Million |
-32.36% |
| 2013-12-31 | ₩25.58 Billion ≈ $17.34 Million |
-16.64% |
| 2012-12-31 | ₩30.69 Billion ≈ $20.80 Million |
-9.22% |
| 2011-12-31 | ₩33.81 Billion ≈ $22.91 Million |
+37.05% |
| 2010-12-31 | ₩24.67 Billion ≈ $16.72 Million |
-- |
About BioSmart Co.Ltd
BioSmart Co.,Ltd. manufactures and sells magnetic stripe (MS) cards in South Korea. The company's magnetic stripe cards include credit cards, smart cards, traffic cards, securities cards, etc. It also sells card equipment, such as traffic card issuing machinery, smart card issuing machinery, credit card issuing machinery, etc.; provides card issuing services comprising MS card and IC chip persona… Read more